RecruitingNot ApplicableNCT06651944

Invisalign® System with Mandibular Advancement

Invisalign® System with Mandibular Advancement Featuring Occlusal Blocks (MAOB) Post-Market Study


Sponsor

Align Technology, Inc.

Enrollment

36 participants

Start Date

Feb 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to observe study participants' comfort and fit of their aligners with occlusal blocks, as well as evaluate the engagement of the blocks using the Invisalign® System with mandibular advancement featuring occlusal blocks


Eligibility

Min Age: 10 YearsMax Age: 16 Years

Inclusion Criteria1

  • • Subject must be eligible for Invisalign treatment with mandibular advancement

Exclusion Criteria2

  • Subject's dentition not compatible with device or allergy to device materials
  • Subject who is pregnant, has active caries, periodontal disease, TMD, root resorption, has HAE (hereditary angioedema), has been diagnosed with epilepsy or any other seizure disorder

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEInvisalign® System with mandibular advancement featuring occlusal blocks

Class II correction using the Invisalign® System with mandibular advancement featuring occlusal blocks


Locations(3)

Astra Orthodontics

Richmond, British Columbia, Canada

MacKenzie Orthodontics

Saint John, New Brunswick, Canada

Discover Orthodontics

Brampton, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06651944


Related Trials